What is Noble Financial’s Forecast for GoHealth Q3 Earnings?

GoHealth, Inc. (NASDAQ:GOCO) – Investment analysts at Noble Financial issued their Q3 2026 earnings estimates for shares of GoHealth in a research note issued on Thursday, April 2nd. Noble Financial analyst M. Kupinski anticipates that the company will post earnings of ($1.99) per share for the quarter. Noble Financial currently has a “Strong-Buy” rating on the stock. The consensus estimate for GoHealth’s current full-year earnings is ($5.50) per share. Noble Financial also issued estimates for GoHealth’s FY2026 earnings at ($8.55) EPS and FY2027 earnings at $1.93 EPS.

GoHealth (NASDAQ:GOCO) last released its quarterly earnings results on Tuesday, March 31st. The company reported ($1.03) earnings per share for the quarter, beating analysts’ consensus estimates of ($2.69) by $1.66. GoHealth had a positive return on equity of 8.00% and a negative net margin of 26.95%.The business had revenue of $12.64 million for the quarter, compared to the consensus estimate of $88.62 million.

A number of other equities analysts have also recently commented on the stock. Freedom Capital cut shares of GoHealth from a “strong-buy” rating to a “hold” rating in a research report on Monday. Weiss Ratings restated a “sell (e+)” rating on shares of GoHealth in a report on Monday, December 29th. One equities research analyst has rated the stock with a Strong Buy rating, three have issued a Hold rating and one has assigned a Sell rating to the company’s stock. Based on data from MarketBeat.com, the stock presently has a consensus rating of “Hold” and a consensus target price of $5.00.

GoHealth Trading Down 9.5%

Shares of GOCO traded down $0.12 during mid-day trading on Tuesday, reaching $1.14. The company’s stock had a trading volume of 65,346 shares, compared to its average volume of 64,493. GoHealth has a 52 week low of $1.13 and a 52 week high of $11.36. The stock has a market cap of $32.73 million, a PE ratio of -0.06 and a beta of 1.61. The company’s fifty day moving average price is $1.71 and its two-hundred day moving average price is $2.74.

Institutional Trading of GoHealth

Several large investors have recently bought and sold shares of the company. Public Sector Pension Investment Board bought a new position in shares of GoHealth in the 3rd quarter worth about $8,100,000. Geode Capital Management LLC grew its holdings in GoHealth by 4.3% in the second quarter. Geode Capital Management LLC now owns 118,961 shares of the company’s stock worth $660,000 after purchasing an additional 4,955 shares during the period. Corient Private Wealth LLC increased its stake in shares of GoHealth by 7.7% during the second quarter. Corient Private Wealth LLC now owns 125,938 shares of the company’s stock valued at $699,000 after purchasing an additional 8,979 shares in the last quarter. Goldman Sachs Group Inc. bought a new position in shares of GoHealth during the fourth quarter valued at approximately $26,000. Finally, Charles Schwab Investment Management Inc. lifted its holdings in shares of GoHealth by 119.3% during the fourth quarter. Charles Schwab Investment Management Inc. now owns 26,448 shares of the company’s stock valued at $57,000 after purchasing an additional 14,388 shares during the last quarter. 24.21% of the stock is owned by institutional investors.

Trending Headlines about GoHealth

Here are the key news stories impacting GoHealth this week:

• Positive Sentiment: Sidoti raised several near‑term and FY2026/FY2027 EPS forecasts, narrowing expected losses (e.g., FY2026 from ($8.86) to ($6.23); FY2027 to ($5.75)), signaling better-than-previously-expected operating trends. This reduces downside risk versus prior forecasts. MarketBeat
• Positive Sentiment: Sidoti materially upgraded Q3 2026 EPS to ($1.47) from ($3.30), and lifted Q1/Q2 2026 estimates modestly — improvement in quarterly trajectory could be viewed as progress toward stabilization. MarketBeat
• Positive Sentiment: Noble Financial upgraded its FY2027 outlook to a positive $1.93 EPS and maintains a “Strong‑Buy” stance, representing a bullish upside scenario if execution improves and revenue accelerates. MarketBeat
• Neutral Sentiment: Sidoti published a full set of quarter‑by‑quarter EPS forecasts through FY2027 (e.g., Q1 2026 ($1.47), Q2 2026 ($1.50), etc.). These provide detailed guidance but keep full‑year consensus still negative, so impact depends on actual execution vs. these forecasts. MarketBeat
• Negative Sentiment: Noble lowered its FY2026 forecast (worse than prior), increasing near‑term downside risk if recovery slips; mixed signals from the same firm increase uncertainty. MarketBeat
• Negative Sentiment: Freedom Capital downgraded GoHealth from “strong‑buy” to “hold,” weighing on sentiment and likely contributing to the share price decline as investors reprice conviction. Zacks

About GoHealth

GoHealth, Inc is a technology-driven health insurance marketplace that connects consumers with a wide range of health insurance plans from leading carriers. Through its digital platform, the company facilitates the comparison, selection and enrollment process for individual and family plans, as well as Medicare Advantage and Medicare Supplement products. By leveraging data analytics and customer support services, GoHealth aims to simplify a traditionally complex market and enable more informed decision-making for policyholders.

The company’s online portal integrates real-time quoting tools, educational resources and access to licensed insurance agents, ensuring that users receive personalized guidance throughout the enrollment journey.